LexDanaLexDanabeta
Inventor

Andrew Tasker

Inventor
Simi Valley, CA, US

Overview

59→
Patents
1993–2016
Patent span
Chemistry
Primary field (CPC C)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07CAcyclic or carbocyclic compounds2%
C04BLime, magnesia2%
C07BGeneral methods of organic chemistry2%
Y02ATechnologies for adaptation to climate change2%
C07KPeptides1%
PatentTitleYear
9,394,297'Amides as pim inhibitors'20169,346,801'Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of use'20169,321,756'Azole compounds as PIM inhibitors'20169,187,486'Bicyclic pyridazine compounds as Pim inhibitors'20159,090,593'Bicyclic compounds as Pim inhibitors'20158,772,481'Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof'20148,642,624'Substituted alkylamine derivatives and methods of use'20148,497,269'Phthalazine compounds as p38 map kinase modulators and methods of use thereof'20138,455,495'Pyridazino-pyridinone compounds and methods of use'20138,435,987'Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof'20138,420,649'Pyrido[3,2-d]pyridazine-2(1H)-one compounds as p38 modulators and methods of use thereof'20138,367,671'Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents'20138,349,831'Calcium receptor modulating agents'20138,338,455'Compounds and methods of use'20128,314,131'Triazole fused heteroaryl compounds and methods of use thereof'20128,247,409'Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use'20128,178,557'Compounds and methods of use'20128,101,612'Phthalazine compounds and methods of use'20128,084,479'Thiazole compounds and methods of use'20118,080,546'Pyrazolo-pyridinone derivatives and methods of use'20118,063,055'Substituted pyridone compounds and methods of use'20118,058,445'Substituted pyridinecarboxamides for the treatment of cancer'20118,022,085'Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof'20118,017,601'Bis-aryl kinase inhibitors and method'20117,989,461'Substituted quinazolinamine compounds for the treatment of cancer'20117,935,709'2-quinazolinone compounds and methods of use'20117,872,128'Benzisoxazole and isoxazolo-pyridine compounds and method of use'20117,846,944'Pyrazolo-pyridinone compounds and methods of use thereof'20107,759,337'Phthalazine compounds and methods of use'20107,745,449'Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use'20107,700,607'Substituted pyridone compounds and methods of use'20107,700,593'Imidazo- and triazolo-pyridine compounds and methods of use thereof'20107,687,643'Process for preparing 3,3-dimethylindolines'20107,652,009'Substituted heterocycles and methods of use'20107,626,030'Compounds and methods of use'20097,514,564'Substituted amine derivatives and methods of use'20097,514,566'Thiazole compounds and methods of use'20097,435,823'Compounds and methods of use'20087,365,093'Endothelin antagonists'20087,354,944'Thiadiazole compounds and methods of use'20087,320,992'Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use'20087,307,088'Substituted anthranilic amide derivatives and methods of use'20077,208,517'Endothelin antagonists'20077,105,682'Substituted amine derivatives and methods of use'20067,101,868'Substituted arylamine derivatives and methods of use'20066,995,162'Substituted alkylamine derivatives and methods of use'20066,946,481'Endothelin antagonists'20056,514,964'Fused cycloheptane and fused azacycloheptane compounds and their methods of use'20036,462,194'Endothelin antagonists'20026,380,241'Treatment of diseases using endothelin antagonists'20026,310,095'Inhibitors of protein isoprenyl transferases'20016,204,293'Inhibitors of protein isoprenyl transferases'20016,162,927'Endothelin antagonists'20006,124,341'Endothelin antagonists'20005,767,144'Endothelin antagonists'19985,731,434'Endothelin antagonists'19985,622,971'Endothelin antagonists'19975,338,726'Endothelin converting enzyme inhibitors'19945,250,548'Angiotensin II receptor antagonists'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2008Patents assigned to ABBOTT LAB (11)· patent assignee history
1993–1994Based in Lindenhurst, IL, US· patent location history
1997–2008Based in Gurnee, IL, US· patent location history
2001–2016Based in Simi Valley, CA, US· patent location history
2003–2016Patents assigned to AMGEN INC (44)· patent assignee history
2010–2016Patents assigned to TASKER ANDREW (20)· patent assignee history
2011–2016Patents assigned to PETTUS LIPING H (11)· patent assignee history
2011–2016Patents assigned to WURZ RYAN (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN INC442003–2016
TASKER ANDREWself202010–2016
ABBOTT LAB111993–2008
PETTUS LIPING H112011–2016
WURZ RYAN82011–2016
Locations
LocationPatentsSpan
Simi Valley, California, US482001–2016
Gurnee, Illinois, US91997–2008
Lindenhurst, Illinois, US21993–1994